FDA Will Not OK GlaxoSmithKline’s (JOBS) Experimental Nausea Drug

Reuters -- The U.S. Food and Drug Administration said it will not approve GlaxoSmithKline Plc's experimental nauseau drug Rezonic for cancer or surgical patients, the drugmaker said on Tuesday.